Resistance to hydroxychloroquine due to smoking in a patient with lupus erythematosus tumidus [26]

British Journal of Dermatology

Volumn 157, Issue 5, 2007, Pages 1081-1083

  Hugel R ^a   Schwarz, T ^a   Glaser R ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Chloroquine; Lupus erythematosus; Smoking

Indexed keywords

CHLOROQUINE; CORTICOSTEROID; HYDROXYCHLOROQUINE;

BLOOD CELL COUNT; BLOOD CHEMISTRY; DRUG EFFICACY; DRUG METABOLISM; DRY EYE; EYELID EDEMA; EYELID ERYTHEMA; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; LETTER; LUPUS ERYTHEMATOSUS; PRIORITY JOURNAL; PSEUDOLYMPHOMA; SMOKING; SMOKING CESSATION; URINALYSIS;

ANTIMALARIALS; DRUG RESISTANCE; FACIAL DERMATOSES; FEMALE; HUMANS; HYDROXYCHLOROQUINE; LUPUS ERYTHEMATOSUS, CUTANEOUS; MIDDLE AGED; SMOKING;

EID: 35348883451     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.08178.x     Document Type: Letter

References (10)

1. Kuhn A, Lehmann P, Ruzicka T. Cutaneous Lupus Erythematosus. Heidelberg:Springer, 2004.
2. Jewell ML, McCauliffe DP. Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment. J Am Acad Dermatol 2000 42:983 7.
3. Rahman P, Gladman DD, Urowitz MB. Smoking interferes with efficacy of antimalarial therapy in cutaneous lupus. J Rheumatol 1998 25:1716 19.
4. Wozniacka A, Carter A, McCauliffe DP. Antimalarials in cutaneous lupus erythematosus: mechanisms of therapeutic benefit. Lupus 2002 11:71 81.
5. Polet H. The effects of lysosomotropic amines on protein degradation, migration of nonhistone proteins to the nucleus, and cathepsin D in lymphocytes. J Cell Physiol 1985 122:415 23.
6. Wanwimolruk S, Wong SM, Coville PF et al. Cigarette smoking enhances the elimination of quinine. Br J Clin Pharmacol 1993 36:610 14.
7. Zevin S, Benowitz NL. Drug interactions with tobacco smoking. An update. Clin Pharmacokinet 1999 36:425 38.
8. Pukrittayakamee S, Pitisuttithum P, Zhang H et al. Effects of cigarette smoking on quinine pharmacokinetics in malaria. Eur J Clin Pharmacol 2002 58:315 19.
9. Kim KA, Park JY, Lee JS et al. Cytochrome P450 2C8 and CYP3A4/5 are involved in chloroquine metabolism in human liver microsomes. Arch Pharm Res 2003 26:631 7.
10. Projean D, Baune B, Farinotti R et al. In vitro metabolism of chloroquine: identification of CYP2C8, CYP3A4, and CYP2D6 as the main isoforms catalyzing N-desethylchloroquine formation. Drug Metab Dispos 2003 31:748 54.